Sumitoma Pharma US
Michael Bokor is a seasoned marketing professional with extensive experience in oncology and strategic key opinion leader engagement. Currently serving as Marketing Director and Thought Leader Liaison for prostate cancer at Sumitomo Pharma America, following the acquisition of Myovant Sciences, Bokor has held several prominent positions, including Director at Myovant Sciences and Regional Marketing Lead at AstraZeneca. With a robust background at Takeda and Astellas Pharma, Bokor has demonstrated expertise in launching successful marketing strategies for high-revenue products, particularly the XTANDI brand, and in building centers of excellence for KOL engagement. Academic qualifications include an MBA in Business Administration and Management from LIU Post.
This person is not in any teams
This person is not in any offices
Sumitoma Pharma US
2 followers
Sumitomo Pharma America (SMPA) is a science-based, technology-driven biopharmaceutical company focused on delivering therapeutic and scientific breakthroughs in areas of critical patient need in oncology, urology, women’s health, rare disease, cell and gene therapies and psychiatry and neurology.